Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-29 | Amended | $11,000,000 | $5,000,000 | Debt Only | 06b | SEC link |
| 2024-08-09 | New | $6,000,000 | $6,000,000 | Debt Only | 06b | SEC link |
| 2022-05-18 | Amended | $25,785,117 | $13,098,792 | Equity Only | 06b | SEC link |
| 2022-01-03 | New | $12,686,325 | $12,686,325 | Equity Only | 06b | SEC link |
| 2021-02-26 | New | $2,155,015 | $2,155,015 | Debt Only | 06b | SEC link |
| 2020-05-04 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
| 2019-08-12 | New | $750,000 | $750,000 | Equity Only | 06b | SEC link |
| 2015-10-27 | New | $3,000,000 | $3,000,000 | Equity Only | 06c | SEC link |
| 2014-11-10 | New | $2,007,827 | $2,007,827 | Equity Only | 06c | SEC link |
| 2013-09-25 | New | $1,268,256 | $1,268,256 | Debt Only | 06c | SEC link |
| Name | Role |
|---|---|
| Robert Armstrong | Director, Executive |
| Robert W. Armstrong, Ph.D. | Director, Executive |
| Casper Breum | Director |
| Jan De Vries, Ph.D. | Director |
| Peter B. Finn | Executive |
| Javier Garcia | Director |
| Andre Hoekema | Director |
| Joseph M. Lobacki | Director, Executive |
| Maria Nichol | Executive |
| Raj Parekh | Director |
| Gino Santini | Director |
| Joe Suarez | Executive |
| Henri Termeer | Director |
| Damia Tormo | Director |
| Damia Tormo, Ph.D. | Director |
| Damia Tormo, Ph.D., Mbm | Director, Executive |
| Alan Walts | Director |